In last trading session, Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) saw 6.47 million shares changing hands with its beta currently measuring 1.07. Company’s recent per share price level of $10.21 trading at $0.36 or 3.65% at ring of the bell on the day assigns it a market valuation of $2.14B. That closing price of BCRX’s stock is at a discount of -8.81% from its 52-week high price of $11.11 and is indicating a premium of 42.21% from its 52-week low price of $5.90.
For Biocryst Pharmaceuticals Inc (BCRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.17. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) trade information
Upright in the green during last session for gaining 3.65%, in the last five days BCRX remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $10.21 price level, adding 2.67% to its value on the day. Biocryst Pharmaceuticals Inc’s shares saw a change of 35.77% in year-to-date performance and have moved 2.92% in past 5-day. Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) showed a performance of 37.97% in past 30-days.
Wall Street analysts have assigned a consensus price target of 16 to the stock, which implies a rise of 36.19% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would jump 31.44% in reaching the projected high whereas dropping to the targeted low would mean a gain of 31.44% for stock’s current value.
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)’s Major holders
BLACKROCK INC. is the top institutional holder at BCRX for having 19.96 million shares of worth $123.33 million. And as of 2024-06-30, it was holding 9.6676 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 18.77 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.0926 of outstanding shares, having a total worth of $116.0 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 6.5 shares of worth $66.32 million or 3.10% of the total outstanding shares. The later fund manager was in possession of 5.43 shares on Mar 31, 2025, making its stake of worth around $55.39 million in the company or a holder of 2.59% of company’s stock.
